Metronidazole-induced and wernicke encephalopathy: Two different entities sharing the same metabolic pathway?

American Journal of Neuroradiology

Volumn 29, Issue 9, 2008, Pages

  Zuccoli, G ^a   Pipitone, N ^b   Santa Cruz, D ^c  

^a Department of Radiology ^*

^b S MARIA NUOVA HOSPITAL   (Italy)

^c HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE;

BRAIN DISEASE; CORPUS CALLOSUM; DENTATE NUCLEUS; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL DISEASE; HUMAN; IMAGE ANALYSIS; LETTER; LIVER CIRRHOSIS; MALABSORPTION; METRONIDAZOLE INDUCED ENCEPHALOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; THIAMINE DEFICIENCY; VESTIBULAR NUCLEUS; WERNICKE ENCEPHALOPATHY;

EID: 54249084130     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1142     Document Type: Letter

References (4)

1. Kim E, Na DG, Kim EY, et al. MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR Am J Neuroradiol 2007;28:1652-58
2. Bae SJ, Lee HK, Lee JH, et al. Wernicke's encephalopathy: atypical manifestation at MR imaging. AJNR Am J Neuroradiol 2001;22:1480-82
3. Kang SY, Kang JH, Choi JC, et al. Wernicke's encephalopathy: unusual manifestation on MRI. J Neurol 2005;252:1550-52
4. Nolli M, Barbieri A, Pinna C, et al. Wernicke's encephalopathy in a malnourished surgical patient: clinical features and magnetic resonance imaging. Acta Anaesthesiol Scand 2005;49:1566-70